ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Professional Issues: AMA Identifies Tobacco-Free Mutual Funds

February 21, 1997

June Panel Meeting Dropped

June 3, 1977

Data-Dredging? Don’t Try It, FDA Says.

May 11, 2007

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

DCPC board Oks New Grant Program For Investigators

March 4, 1994

October issue of Business & Regulatory Report included.

November 5, 2004